Skip to main content

TRANSFORMANDO LAS NUEVAS TECNOLOGIAS DE SECUENCIACION EN UNA HERRAMIENTA PARA LA EPIDEMIOLOGIA Y DIAGNOSTICO DE LA TUBERCULOSIS: DEL LABORATORIO A LA CLINICA

SAF2013-43521-R

•
Funding agency name Ministerio de Economía y Competitividad
Funding agency acronym MINECO
Program Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Call Proyectos I+D+i Retos de Investigación
Call year 2013
State Plan 2013-2016 Plan Estatal de Investigación Científica y Técnica y de Innovación
Management unit Secretaría de Estado de Educación, Formación Profesional y Universidades
Beneficiary centre FUNDACION PARA EL FOMENTO DE LA INVESTIGACION SANITARIA Y BIOMEDICA EN LA COMUNITAT VALENCIANA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 12
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Draft Genome Sequence of Mycobacterium brumae ATCC 51384

  • D'Auria, Giuseppe
  • Torrents, Eduard
  • Luquin, Marina
  • Comas, Iñaki
  • Julián, Esther
2 pág., 2 enlaces al European Nucleotide archive., Here, we report the draft genome sequence of Mycobacterium brumae type strain ATCC 51384. This is the first draft genome sequence of M. brumae, a nonpathogenic, rapidly growing, nonchromogenic mycobacterium, with immunotherapeutic capacities., This work, including the efforts of Iñaki Comas, was funded by EC| European Research Council (ERC) (638553-TB-ACCELERATE). This work, including the efforts of Iñaki Comas, was funded by Ministerio de Economíay Competitividad (MINECO) (RYC-2012-10627andSAF2013-43521-R). This work, including the efforts of Marina Luquin and Esther Julián, was funded by Generalitat de Catalunya (GovernmentofCatalonia) (2014SGR-132). This work, including the efforts of Eduard Torrents, was funded by GeneralitatdeCatalunya (GovernmentofCata-lonia) (2014SGR-01260)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

New Genome-Wide Algorithm Identifies Novel In-Vivo Expressed Mycobacterium Tuberculosis Antigens Inducing Human T-Cell Responses with Classical and Unconventional Cytokine Profiles

  • Coppola, Mariateresa
  • van Meijgaarden, Krista E.
  • Franken, Kees L. M. C.
  • Commandeur, Susanna
  • Dolganov, Gregory
  • Kramnik, Igor
  • Schoolni, Gary K.
  • Comas, Iñaki
  • Lund, Ole
  • Prins, Corine
  • van den Eeden, Susan J. F.
  • Korsvold, Gro E.
  • Oftung, Fredrik
  • Geluk, Annemieke
  • Ottenhof, Tom H. M.
16 páginas, 8 figuras. Disponoble información suplementaria en: http://www.nature.com/srep, New strategies are needed to develop better tools to control TB, including identification of novel antigens for vaccination. Such Mtb antigens must be expressed during Mtb infection in the major target organ, the lung, and must be capable of eliciting human immune responses. Using genome-wide transcriptomics of Mtb infected lungs we developed data sets and methods to identify IVE-TB (in-vivo expressed Mtb) antigens expressed in the lung. Quantitative expression analysis of 2,068 Mtb genes from the predicted first operons identified the most upregulated IVE-TB genes during in-vivo pulmonary infection. By further analysing high-level conservation among whole-genome sequenced Mtb-complex strains (n = 219) and algorithms predicting HLA-class-Ia and II presented epitopes, we selected the most promising IVE-TB candidate antigens. Several of these were recognized by T-cells from in-vitro Mtb-PPD and ESAT6/CFP10-positive donors by proliferation and multi-cytokine production. This was validated in an independent cohort of latently Mtb-infected individuals. Significant T-cell responses were observed in the absence of IFN-γ-production. Collectively, the results underscore the power of our novel antigen discovery approach in identifying Mtb antigens, including those that induce unconventional T-cell responses, which may provide important novel tools for TB vaccination and biomarker profiling. Our generic approach is applicable to other infectious diseases., We acknowledge funding by EC HORIZON2020 TBVAC2020 (Grant Agreement No. 643381); EC ITN FP7 VACTRAIN project (the text represents the authors’ views and does not necessarily represent a position of the Commission who will not be liable for the use made of such information), The Netherlands Organization for Scientific Research (NWO-TOP Grant Agreement No. 91214038); European Research Council (ERC TB-ACCELERATE Grant Agreement No. 638553). Funding was also supplied by the Ministerio de Economía y Competitividad (Spanish Government) research grant SAF2013-43521-R, and the European Research Council (ERC) (638553-TB-ACCELERATE) (to IC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

In-Depth Characterization and Functional Analysis of Clonal Variants in a Mycobacterium tuberculosis Strain Prone to Microevolution

  • Navarro, Yurena
  • Pérez-Lago, Laura
  • Herranz, Marta
  • Sierra, Olalla
  • Comas, Iñaki
  • Sicilia, Javier
  • Bouza, Emilio
  • García de Viedma, Darío
The role of clonal complexity has gradually been accepted in infection by Mycobacterium tuberculosis (MTB), although analyses of this issue are limited. We performed an in-depth study of a case of recurrent MTB infection by integrating genotyping, whole genome sequencing, analysis of gene expression and infectivity in in vitro and in vivo models. Four different clonal variants were identified from independent intrapatient evolutionary branches. One of the single-nucleotide polymorphisms in the variants mapped in mce3R, which encodes a repressor of an operon involved in virulence, and affected expression of the operon. Competitive in vivo and in vitro co-infection assays revealed higher infective efficiency for one of the clonal variants. A new clonal variant, which had not been observed in the clinical isolates, emerged in the infection assays and showed higher fitness than its parental strain. The analysis of other patients involved in the same transmission cluster revealed new clonal variants acquired through novel evolutionary routes, indicating a high tendency toward microevolution in some strains that is not host-dependent. Our study highlights the need for integration of various approaches to advance our knowledge of the role and significance of microevolution in tuberculosis., This study was funded by the Ministry of Economy and Competitiveness ISCIII-FIS (PI15/01554) and co-funded by ERDF (FEDER) funds from the European Commission, “A way of making Europe.” Research by YN was supported by a PICATA pre-doctoral fellowship (BE55/11) from the Moncloa Campus of International Excellence (UCM-UPM, Instituto de Investigación Sanitaria Gregorio Marañón). LP-L was supported by a Miguel Servet contract (MS15/00075- CP15/00075). IC lab is financed by Ministerio de Economía y Competitividad (Spanish Government) research grant SAF2013- 43521-R, SAF2016-77346-R, and the European Research Council (ERC) (638553-TB-ACCELERATE)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Otros (Other)

Genomic Epidemiology of Tuberculosis

  • Comas, Iñaki
Gagneux, S. (ed) .-- 16 páginas, The application of next generation sequencing technologies has opened the door to a new molecular epidemiology of tuberculosis, in which we can now look at transmission at a resolution not possible before. At the same time, new technical and analytical challenges have appeared, and we are still exploring the wider potential of this new technology. Whole genome sequencing in tuberculosis still requires bacterial cultures. Thus, although whole genome sequencing has revolutionized the interpretation of transmission patterns, it is not yet ready to be applied at the point-of-care. In this chapter, I will review the promises and challenges of genomic epidemiology, as well as some of the new questions that have arisen from the use of this new technology. In addition, I will examine the role of molecular epidemiology within the general frame of global tuberculosis control and how genomic epidemiology can contribute towards the elimination of the disease., Work in my laboratory is supported by the Spanish National Foundation (MINECO SAF2013-43521-R) and the European Research Council (638553-TB-ACCELERATE)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

A novel strategy based on genomics and specific PCR reveals how a multidrug-resistant Mycobacterium tuberculosis strain became prevalent in Equatorial Guinea 15 years after its emergence

  • Pérez-Lago, Laura
  • Herranz, Marta
  • Comas, Iñaki
  • Sierra, Olalla
  • Bouza, Emilio
  • García de Viedma, Darío
et al., [Objective]: Molecular epidemiology techniques in tuberculosis (TB) can identify high-risk strains that are actively transmitted. We aimed to implement a novel strategy to optimize the identification and control of multidrug-resistant (MDR) TB in a specific population. [Methods]: We developed a strain-specific PCR tailored from whole genome sequencing (WGS) data to track a specific MDR prevalent strain in Equatorial Guinea (EG-MDR). [Results]: The PCR was applied prospectively on remnants of GeneXpert reaction mixtures owing to the lack of culture facilities in Equatorial Guinea. In 147 (93%) of 158 cases, we were able to differentiate between infection by the EG-MDR strain or by any other strain and found that 44% of all rifampicin-resistant TB cases were infected by EG-MDR. We also analysed 93 isolates obtained from Equatorial Guinea 15 years ago, before MDR-TB had become the problem it is today. We found that two of the scarce historical MDR cases were infected by EG-MDR. WGS revealed low variability-six single nucleotide polymorphisms acquired by this strain over 15 years-likely because of the lack in the country of a specific program to treat MDR-TB. [Conclusions]: Our novel strategy, which integrated WGS analysis and strain-specific PCRs, represents a low-cost, rapid and transferable strategy that allowed a prospective efficient survey and fast historical analysis of MDR-TB in a population., This study was funded by Plan Estatal I+D+I 2013-2016, ISCIII (13/01207; 15/01554) and cofunded by the Fondo Europeo de Desarrollo Regional (FEDER): “Una manera de hacer Europa”. We also received funding from Fondation Merieux (DM/CL/cb15) and a Grant for International Cooperation Projects from the IiSGM (I and II-COOP-INT 2015). L.P. holds a Miguel Servet research grant (CP15/00075), MINECO research grant (SAF2013-43521-R); I.C. holds a European Research Council (ERC) grant (638553-TB-ACCELERATE). Funding was also received from the Spanish Network for Research in Infectious Diseases (REIPI, RD12/0015 to GT)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

The Troika Host-Pathogen-Extrinsic Factors in Tuberculosis: Modulating Inflammation and Clinical Outcomes

  • Novais Bastos, Helder
  • Osório, Nuno S.
  • Gagneux, Sebastien
  • Comas, Iñaki
  • Saraiva, Margarida
The already enormous burden caused by tuberculosis (TB) will be further aggravated by the association of this disease with modern epidemics, as human immunodeficiency virus and diabetes. Furthermore, the increasingly aging population and the wider use of suppressive immune therapies hold the potential to enhance the incidence of TB. New preventive and therapeutic strategies based on recent advances on our understanding of TB are thus needed. In particular, understanding the intricate network of events modulating inflammation in TB will help to build more effective vaccines and host-directed therapies to stop TB. This review integrates the impact of host, pathogen, and extrinsic factors on inflammation and the almost scientifically unexplored complexity emerging from the interactions between these three factors. We highlight the exciting data showing a contribution of this troika for the clinical outcome of TB and the need of incorporating it when developing novel strategies to rewire the immune response in TB., HN-B acknowledges the receipt of research scholarships from Bolsa D. Manuel de Mello and the Portuguese Society for Pneumology. NO acknowledges FCT IF/00474/2014. SG is funded by the European Research Council (grant number 309540-EVODRTB); the Swiss National Science Foundation (grant number 310030_166687) SystemsX.ch. IC lab is financed by Ministerio de Economía y Competitividad (Spanish Government) research grant SAF2013-43521-R, SAF2016-77346-R, and PROMETEO/2016/122 from Generalitat Valenciana and the European Research Council (ERC) (638553-TB-ACCELERATE). The MS lab is financed by FEDER—Fundo Europeu de Desenvolvimento Regional funds through the COMPETE 2020—Operacional Programme for Competitiveness and Internationalisation (POCI), Portugal 2020, and by Portuguese funds through FCT in the framework of the project “Institute for Research and Innovation in Health Sciences” (POCI-01-0145-FEDER-007274). MS is an FCT Principal Investigator. Some graphical elements in the figures were designed by kjpargeter/Freepik. The funding agencies had no role in the design of the manuscript., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Development and application of affordable SNP typing approaches to genotype Mycobacterium tuberculosis complex strains in low and high burden countries

  • Cancino-Muñoz, Irving
  • Gil-Brusola, Ana
  • Torres-Puente, Manuela
  • Mariner-Llicer, Carla
  • Dogba, John
  • Akinseye, Victor
  • Adesokan, Kehinde
  • Kwaghe, Ayi
  • Ejeh, Francis
  • Cadmus, Simeon
  • Comas, Iñaki
12 páginas, 6 figuras, 4 tablas, The Mycobacterium tuberculosis complex (MTBC) comprises the species that causes tuberculosis (TB) which affects 10 million people every year. A robust classification of species, lineages, and sub-lineages is important to explore associations with drug resistance, epidemiological patterns or clinical outcomes. We present a rapid and easy-to-follow methodology to classify clinical TB samples into the main MTBC clades. Approaches are based on the identification of lineage and sub-lineage diagnostic SNP using a real-time PCR high resolution melting assay and classic Sanger sequencing from low-concentrated, low quality DNA. Thus, suitable for implementation in middle and low-income countries. Once we validated our molecular procedures, we characterized a total of 491 biological samples from human and cattle hosts, representing countries with different TB burden. Overall, we managed to genotype ~95% of all samples despite coming from unpurified and low-concentrated DNA. Our approach also allowed us to detect zoonotic cases in eight human samples from Nigeria. To conclude, the molecular techniques we have developed, are accurate, discriminative and reproducible. Furthermore, it costs less than other classic typing methods, resulting in an affordable alternative method in TB laboratories., This work was supported by European Research Council (grant, 638553-TB-ACCELERATE) and the Ministerio de Economía y Competitividad grants (SAF2013-43521-R and SAF2016-77346-R) both to I.C., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Influence of Gut Microbiota on Progression to Tuberculosis Generated by High Fat Diet-Induced Obesity in C3HeB/FeJ Mice

  • Arias, Lilibeth
  • Goig, Galo A.
  • Cardona, Paula
  • Torres-Puente, Manuela
  • Díaz, Jorge
  • Rosales, Yaiza
  • Garcia, Eric
  • Tapia, Gustavo
  • Comas, Iñaki
  • Vilaplana, Cristina
  • Cardona, Pere-Joan
18 páginas, 11 figuras, 3 tablas. Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fimmu.2019.02464/full#supplementary-material, The administration of a high fat content diet is an accelerating factor for metabolic syndrome, impaired glucose tolerance, and early type 2 diabetes. The present study aims to assess the impact of a high fat diet on tuberculosis progression and microbiota composition in an experimental animal model using a C3HeB/FeJ mouse strain submitted to single or multiple consecutive aerosol infections. These models allowed us to study the protection induced by Bacillus Calmette-Guérin vaccination as well as by the natural immunity induced by chemotherapy after a low dose Mycobacterium tuberculosis infection. Our results show that a high fat diet is able to trigger a pro-inflammatory response, which results in a faster progression toward active tuberculosis and an impaired protective effect of BCG vaccination, which is not the case for natural immunity. This may be related to dysbiosis and a reduction in the Firmicutes/Bacteroidetes ratio in the gut microbiota caused by a decrease in the abundance of the Porphyromonadaceae family and, in particular, the Barnesiella genus. It should also be noted that a high fat diet is also related to an increase in the genera Alistipes, Parasuterella, Mucispirillum, and Akkermansia, which have previously been related to dysbiotic processes. As diabetes mellitus type 2 is a risk factor for developing tuberculosis, these findings may prove useful in the search for new prophylactic strategies for this population subset., This work was supported by the European Commission Horizon 2020 research and innovation program under grant agreement TBVAC2020 No. 643381, European Research Council research grant 638553-TB-ACCELERATE and Ministerio de Economía y Competitividad (Spanish government) research grant SAF2017-92345- EXP (to IC). CV has a project Servet II contract funded by the Instituto de Salud Carlos III (ISCIII, CPII 18/00031). LA received an Improvement and Mobility Program grant from the Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES). GG contract was funded by Ministerio de Economia y Competitividad (Spanish Government) (BES-2014-071066). PC contract was funded by the Instituto de Salud Carlos III (IFI14/00015). The Experimental Tuberculosis Unit is accredited by the Catalan Agency for Management of University and Research Grants with code 2017 SGR500 and the IGTP is a member of the CERCA network of institutes. The funders played no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Towards next-generation diagnostics for tuberculosis: identification of novel molecular targets by large-scale comparative genomics

  • Goig, Galo A.
  • Torres-Puente, Manuela
  • Mariner-Llicer, Carla
  • Villamayor, Luis M.
  • Chiner-Oms, Álvaro
  • Gil-Brusola, Ana
  • Borrás, Rafael
  • Comas, Iñaki
5 páginas, 2 figuras. AVAILABILITY AND IMPLEMENTATION: The database of non-tuberculous mycobacteria assemblies can be accessed at: 10.5281/zenodo.3374377. SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online: http://dx.doi.org/10.1093/bioinformatics/btz729, MOTIVATION: Tuberculosis (TB) remains one of the main causes of death worldwide. The long and cumbersome process of culturing Mycobacterium tuberculosis complex (MTBC) bacteria has encouraged the development of specific molecular tools for detecting the pathogen. Most of these tools aim to become novel TB diagnostics, and big efforts and resources are invested in their development, looking for the endorsement of the main public health agencies. Surprisingly, no study has been conducted where the vast amount of genomic data available is used to identify the best MTBC diagnostic markers. RESULTS: In this work, we used large-scale comparative genomics to identify 40 MTBC-specific loci. We assessed their genetic diversity and physiological features to select 30 that are good targets for diagnostic purposes. Some of these markers could be used to assess the physiological status of the bacilli. Remarkably, none of the most used MTBC markers is in our catalog. Illustrating the translational potential of our work, we develop a specific qPCR assay for quantification and identification of MTBC DNA. Our rational design of targeted molecular assays for TB could be used in many other fields of clinical and basic research., This work was supported by projects of the European Research Council (ERC) (638553-TB-ACCELERATE), Ministerio de Economía y Competitividad and Ministerio de Ciencia, Innovación y Universidades (Spanish Government), SAF2013-43521-R, SAF2016-77346-R and SAF2017–92345–EXP (to I.C.), BES-2014-071066 (to G.A.G.), FPU 13/00913 (to A.C.O.)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Tuberculosis in Liberia: high multidrug-resistance burden, transmission and diversity modelled by multiple importation events

  • López, Mariana G.
  • Dogba, John B.
  • Torres-Puente, Manuela
  • Goig, Galo A.
  • Moreno-Molina, Miguel
  • Villamayor, Luis M.
  • Cadmus, Simeon
  • Comas, Iñaki
12 páginas, 5 figuras, 2 tablas. DNA sequences generated as part of this study have been deposited at the European Nucleotide Archive under study accession number PRJEB32589 (Table S1) (2019), Tuberculosis (TB) surveillance is scarce in most African countries, even though it is the continent with the greatest disease incidence according to the World Health Organization. Liberia is within the 30 countries with the highest TB burden, probably as a consequence of the long civil war and the recent Ebola outbreak, both crippling the health system and depreciating the TB prevention and control programmes. Due to difficulties working in the country, there is a lack of resistance surveys and bacillus characterization. Here, we use genome sequencing of Mycobacterium tuberculosis clinical isolates to fill this gap. Our results highlight that the bacillus population structure is dominated by lineage 4 strains that harbour an outstanding genetic diversity, higher than in the rest of Africa as a whole. Coalescent analyses demonstrate that strains currently circulating in Liberia were introduced several times beginning in the early year 600 CE until very recently coinciding with migratory movements associated with the civil war and Ebola epidemics. A higher multidrug-resistant (MDR)-TB frequency (23.5 %) than current estimates was obtained together with non-catalogued drug-resistance mutations. Additionally, 39 % of strains were in genomic clusters revealing that ongoing transmission is a major contribution to the TB burden in the country. Our report emphasizes the importance of TB surveillance and control in African countries where bacillus diversity, MDR-TB prevalence and transmission are coalescing to jeopardize TB control programmes., This work was supported by the European Research Council (638553-TB-ACCELERATE) and the Ministerio de Economía y Competitividad (SAF2013-43521-R and SAF2016-77346-R to I.C.). Funding support from the John D. and Catherine T. MacArthur Foundation, USA, under the Higher Education Initiative in Africa (grant no. 97944-0-800/406/99) for the establishment of the Center for Control and Prevention of Zoonoses, University of Ibadan, Nigeria, is appreciated., Peer reviewed
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Draft genome sequences of Mycobacterium setense type strain DSM-45070 and the nonpathogenic strain Manresensis, isolated from the bank of the Cardener river in Manresa, Catalonia, Spain

  • Rech, Gabriel
  • Vilaplana i Massaguer, Cristina
  • Velasco, Juan
  • Pluvinet, Raquel
  • Santín, Sheila
  • Julián, Esther|||0000-0002-6558-3978
  • Alcaide, Fernando|||0000-0002-4097-1499
  • Comas, I.|||0000-0001-5504-9408
  • Sumoy, Lauro|||0000-0003-0005-4618
  • Cardona, Pere-Joan|||0000-0001-5623-7873
We present here the draft genome sequences of two Mycobacterium setense strains. One of them corresponds to the M. setense type strain DSM-45070, originally isolated from a patient with a posttraumatic chronic skin abscess. The other one corresponds to the nonpathogenic M. setense strain Manresensis, isolated from the Cardener River crossing Manresa, Catalonia, Spain. A comparative genomic analysis shows a smaller genome size and fewer genes in M. setense strain Manresensis relative to those of the type strain, and it shows the genome segments unique to each strain.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Draft Genome Sequence of Mycobacterium brumae ATCC 51384

  • D'Auria, Giuseppe|||0000-0003-0672-2541
  • Torrents, Eduard|||0000-0002-3010-1609
  • Luquin Fernandez, Marina de la Milagrosa|||0000-0002-6015-3282
  • Comas, I.|||0000-0001-5504-9408
  • Julián, Esther|||0000-0002-6558-3978
Here, we report the draft genome sequence of Mycobacterium brumae type strain ATCC 51384. This is the first draft genome sequence of M. brumae, a nonpathogenic, rapidly growing, nonchromogenic mycobacterium, with immunotherapeutic capacities.